Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
range-finding study for a prenatale development toxicity study OECD 414

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1988

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
Version / remarks:
range-finding study
Principles of method if other than guideline:
5 animals/dose
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
3-methylbutan-1-ol
EC Number:
204-633-5
EC Name:
3-methylbutan-1-ol
Cas Number:
123-51-3
Molecular formula:
C5H12O
IUPAC Name:
3-methylbutan-1-ol
Details on test material:
- Name of test material (as cited in study report): 3-methyl-l-butanol
- Test substance No. 88/56 [H 21670]
- Physical state: liquid/colourless
- Analytical purity: 98.6% (acc. toreport Feb 2, 1988)
- Stability under test conditions: The stability was ensured for the study period under the specified storage conditions by reanalysis ( see report of Nov 25, 1988)
- Storage condition of test material: at roomtemperature

Test animals

Species:
rat
Strain:
Wistar
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: female Wistar rats (strain: SPF-Wistar/Chbb:THOM; breeding facilities: Dr. K. Thomae GmbH, D-7950 Biberach/Riss, FRG). The animals were free from any clinically evident signs prior to the beginning of the study.
- Age at study initiation: ca 11 weeks
- Weight at study initiation: ca 216 g
- Housing: singly in wire cages (type D III of Becker & Co, Castrop-Rauxel, FRG)
- Diet (e.g. ad libitum): KLIBA rat/mouse laboratory diet 24-343-4 10 mm pellets, Klingentalmühle AG, CH-4303 Kaiseraugst, Switzerland; during the exposure-free observation period
- Water (e.g. ad libitum): tap water; during the exposure-free observation period
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS in fully air-conditioned rooms
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Route of administration:
inhalation: vapour
Type of inhalation exposure (if applicable):
whole body
Vehicle:
unchanged (no vehicle)
Details on exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: the animals were exposed singly in wire cages (D III) in glass-steel inhalation chambers (manufacturer: BASF Aktiengesellschaft), Volume Vz 1,100 1 (test group 1, 2 and 3), Volume V 2 1,600 1 (test group 0 and parts of the test groups during the preflow period).
- Method of holding animals in test chamber: whole-body exposure system (glass-steel inhalation chamber) with a volume of about 1.1 m3 (test groups 1 - 3); volume of the inhalation chamber of the control group: 1.6 m3
- Source and rate of air: the test substance was supplied by means of two continuously driven piston pumps (Unita, Braun) in test
group 1, a continuously metering pump (Optimat MP) in test group 2, and another continuously metering pump (Desaga) in test gorup 3 to a vaporizer heated with a circulating thermostat and evaporated. The evaporation temperatures are shown in the following table.

_______________________________________________________________________________
Test group /ml/hour /Evaporation temperature (°C) /Supply air (l/hour) /Exhaust air (l/hour)
-----------------------------------------------------------------------------------------------------------------------
0 /Fresh air /- /30000 /29500
1 /13.7 - 14.3 /50 /21500 /22000
2 /75.6 - 82.8 /60 /21500 /22000
3 /295 - 305 /70 /21500 /22000
_______________________________________________________________________________

A stream of fresh air measured with a rotameter took up the vapors. A further stream of fresh air was passed in downstream of the vaporizer. After passing through a mixing device, this mixture of vapors and air was supplied to exposure system

- Temperature, humidity, pressure in air chamber: the pressure in the inhalation chambers was measured continuously (inclined manometer) and recorded, as a rule, 3 times/exposure. Conditioned supply air ( about 50% humidity, 22 °C) was used for the exposure in all test groups. The temperature in the exposure systems was measured continuously (digital thermometer, Diehl) and recorded, as a rule, 3 times/exposure. The relative humidity in the chambers was checked with a humidity measuring probe (Vaisala) at least once a day and also recorded.
- Air flow rate: all air flows, supply air and exhaust air were adjusted by means of flowmeters (rotameter) for all test groups and recorded, as a rule, 6 times/exposure.

TEST ATMOSPHERE
- Brief description of analytical method used: the concentration in the inhalation chambers was monitored by means of a GC-method. The concentrations of the test groups were analyzed by gas chromatography after absorption of MEB samples in 2-propanol.
The gas chromatographs were calibrated with weighed amounts of the test substance.
- Samples taken from breathing zone: yes
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
gas chromatograph monitoring
Duration of treatment / exposure:
gestational days 6 - 15
Frequency of treatment:
6 hours/day
Duration of test:
20 days
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0.5, 2.5, 5.0 mg/l
Basis:
nominal conc.
Remarks:
Doses / Concentrations:
0.53 ± 0.007, 2.50 ± 0.11 and 5.1 ± 0.16 mg/l
Basis:
analytical conc.
gas chromatograph monitoring
No. of animals per sex per dose:
10 (5 in the main groups, 5 in the satellite groups)
Control animals:
yes, concurrent no treatment
Details on study design:
- Other: cesarean of dams at days 20 p.c.

Examinations

Maternal examinations:
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: the behavior and state of health of the test animals were checked on workdays at least 3 times on exposure days and, as a rule, once during the post-exposure observation period.

POST-MORTEM EXAMINATIONS: Yes
- Organs examined: gross patology including placenta weights

OTHER: a check for dead animals was made daily. hematologically examination in the satellite groups
Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
Fetal examinations:
- External examinations: Yes:

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects:no effects

Effect levels (maternal animals)

Dose descriptor:
NOAEC
Effect level:
5 mg/L air (nominal)
Basis for effect level:
other: maternal toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:no effects

Effect levels (fetuses)

Dose descriptor:
NOAEC
Effect level:
5 mg/L air (nominal)
Basis for effect level:
other: teratogenicity

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

Dams: no clinical symptoms seen. At 5.1 mg/l it was unclear if a slight retardation of body weight increase occurred. Haematology and clinical-chemical examinations did not show any substance-related effects. Reproductive parameters, fetal and placental weights were unchanged. Fetuses did not show any macroscopic changes.

Applicant's summary and conclusion